Padcev-Keytruda Combo Lands Another Win in Bladder Cancer

(MedPage Today) — SAN FRANCISCO — Perioperative treatment with enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) significantly improved survival compared with standard neoadjuvant chemotherapy in patients with muscle-invasive bladder…

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120087

Author :

Publish date : 2026-02-27 20:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Padcev-Keytruda Combo Lands Another Win in Bladder Cancer

Tiny Blood Smidges in the Brain: Amount and Location Tied to Dementia

Casey Means’ Cringey Senate Hearing Should Sink Her Surgeon General Bid

Related Posts

Real-World Use of Upadacitinib Effective in Perianal Crohn’s

IL-23 Inhibitors Linked to Lower PsA Risk in Psoriasis Study

Ped Subspecialty Training Changes Raise Concerns, Questions

The Global Story – The AI chatbot users falling into delusional spirals

The mathematician who doesn’t exist

FDA Neurology Roundup: April 2026

Real-World Use of Upadacitinib Effective in Perianal Crohn’s

IL-23 Inhibitors Linked to Lower PsA Risk in Psoriasis Study

Ped Subspecialty Training Changes Raise Concerns, Questions

The Global Story – The AI chatbot users falling into delusional spirals

The mathematician who doesn’t exist

FDA Neurology Roundup: April 2026

Could AI Copilots Reduce Clinician Documentation Time?

Ethiopian woman’s joy at rare quintuplets after 12 years trying for a baby

Categories

Archives